• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • News

    Nigeria

    By Brian Kenety // 26 March 2010

    Related Stories

    The top global development employers hiring in Nigeria in 2025
    The top global development employers hiring in Nigeria in 2025
    Devex Newswire: How one nonprofit beat the odds and survived Trump’s purge
    Devex Newswire: How one nonprofit beat the odds and survived Trump’s purge
    Devex Newswire: UK aid cuts hit Sudan and Sierra Leone front-line efforts
    Devex Newswire: UK aid cuts hit Sudan and Sierra Leone front-line efforts
    Devex CheckUp: Ozempic generics — promises galore, pitfalls aplenty
    Devex CheckUp: Ozempic generics — promises galore, pitfalls aplenty

    Nigeria’s Acting President Goodluck Jonathan will meet former rebel leaders from the oil-producing Niger Delta on March 26, hoping to get a federal amnesty program back on track. “The meeting is to assure former militants of the commitment of the government to the post-amnesty program and the development of the Niger Delta region,” a presidency source told Reuters. Little progress has been made in implementing the amnesty program, the most comprehensive peace effort in the Niger Delta for years, since President Umaru Yar’Adua fell seriously ill last November. Recent militant attacks have threatened to undermine the peace process further and prolong the unrest, which has kept Nigeria from pumping much more than two thirds of its 3 million barrels per day oil capacity. Jonathan, who took over executive powers last month in Yar’Adua’s absence, has made restoring peace in the Niger Delta a top priority. (Reuters)

    • Democracy, Human Rights & Governance
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Brian Kenety

      Brian Kenety

    Search for articles

    Related Stories

    Job Board InsightsRelated Stories - The top global development employers hiring in Nigeria in 2025

    The top global development employers hiring in Nigeria in 2025

    Devex NewswireRelated Stories - Devex Newswire: How one nonprofit beat the odds and survived Trump’s purge

    Devex Newswire: How one nonprofit beat the odds and survived Trump’s purge

    Devex NewswireRelated Stories - Devex Newswire: UK aid cuts hit Sudan and Sierra Leone front-line efforts

    Devex Newswire: UK aid cuts hit Sudan and Sierra Leone front-line efforts

    Devex CheckUpRelated Stories - Devex CheckUp: Ozempic generics — promises galore, pitfalls aplenty

    Devex CheckUp: Ozempic generics — promises galore, pitfalls aplenty

    Most Read

    • 1
      Building stronger primary care to tackle NCDs and mental health
    • 2
      Investing in opportunity: How venture capital powers social impact
    • 3
      Meet the innovators closing persistent gaps in women's health
    • 4
      Collaborating for greater impact — Rwanda’s fight against AMR
    • 5
      Opinion: Learning from global development can help rural America
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement